- Home
- JANX vs MCBS Comparison
JANX vs MCBS Comparison
Compare JANX & MCBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | JANX | MCBS |
|---|---|---|
| Founded | 2017 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 790.3M | 816.1M |
| IPO Year | 2021 | 2019 |
Fundamental Metrics
Financial Performance| Metric | JANX | MCBS |
|---|---|---|
| Price | $14.08 | $32.45 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 13 | 1 |
| Target Price | ★ $47.00 | $33.00 |
| AVG Volume (30 Days) | ★ 879.6K | 61.3K |
| Earning Date | 05-08-2026 | 04-24-2026 |
| Dividend Yield | N/A | ★ 3.63% |
| EPS Growth | N/A | ★ 4.76 |
| EPS | N/A | ★ 2.64 |
| Revenue | ★ $10,000,000.00 | N/A |
| Revenue This Year | N/A | $36.78 |
| Revenue Next Year | N/A | $2.44 |
| P/E Ratio | ★ N/A | $12.33 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $12.12 | $24.53 |
| 52 Week High | $35.34 | $33.40 |
Technical Indicators
Market Signals| Indicator | JANX | MCBS |
|---|---|---|
| Relative Strength Index (RSI) | 43.34 | 61.97 |
| Support Level | $13.88 | $26.91 |
| Resistance Level | $14.44 | $33.24 |
| Average True Range (ATR) | 0.55 | 0.83 |
| MACD | -0.11 | -0.05 |
| Stochastic Oscillator | 13.63 | 67.80 |
Price Performance
Historical ComparisonAbout JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr). The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.
About MCBS MetroCity Bankshares Inc.
MetroCity Bankshares Inc is a holding company of its subsidiary Metro City Bank. It provides commercial banking services such as consumer and commercial checking accounts, savings accounts, certificates of deposits, commercial and consumer loans, money transfers and a variety of other banking services. The banks generate revenue from interest income. Its customers include small business owners, professionals, consumers, and real estate developers.